News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- STAT Plus: Disappointing trial results dim hopes for a new class of pain drugs
- Two-wave U.S. flu season is now the longest in a decade
- Get tested, starting at home: Quest launches direct ordering of STD diagnostic kits
- Bausch Health is far from the LeBron James in eye care, so don’t compare it to Alcon: analyst
- STAT Plus: Up and down the ladder: The latest comings and goings
- Federal judge scolds Purdue, Endo and Mallinckrodt for stall tactics in opioids case
- Aidoc raises $27M, analyzes its one-millionth CT scan
- STAT Plus: Pharmalittle: A Pfizer and Lilly painkiller misses study goals; LA County joins statewide effort to lower drug prices
- BI and Lilly’s diabetes drug Jardiance reverses heart failure in animal models
- Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More
- Lilly, Pfizer’s phase 3 pain data show mixed efficacy, clear safety issues
- FiercePharmaAsia—Indian generics contenders; Chi-Med’s HK listing; Qilu Pharma explosion
- STAT Plus: Drugging the undruggable and other challenges on the road to targeting RNA with pills
- Opinion: What my polio-stricken mother would tell parents today about the importance of immunization
- A pivotal test of an experimental malaria vaccine set to begin